http://www.acc.org/Feed?clinicalTopicID=a111dd2d-31c2-4097-b779-01457a536a5e Clinical Topic Feed: Cardio-Oncology en /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1790848980000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/29/11/11/Statins-For-the-Prevention-of-Anthracycline-Induced-Cardiotoxicity Anthracycline-induced cardiotoxicity is a major contributor to long-term cardiovascular (CV) outcomes in survivors of cancer. Up to 20% of patients exposed to anthracyclines develop irreversible cardiomyopathy through mechanisms leading to cardiomyocyte death. 1790695860000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/23/14/28/eagles-eye-view-23sep2026 In this week’s View, Dr. Eagle looks at a recent JACC: Advances Viewpoint that examines the challenges associated with implementing revisions to the definition of first medical contact (FMC) introduced in the 2025 ACC/AHA ACS Guideline and its implications for NCDR data collection. 1790173860000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/21/17/24/Beyond-the-Tumor ASCVD prevention has historically targeted the general adult population, with survivors of cancer and patients with active cancer being underrepresented. Cancer and its therapies may increase cardiovascular (CV) risk and accelerate vascular disease through treatment-related dyslipidemia... 1790093640000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/09/10/19/19/JACC-CardioOncology-Primer As the use of antibody-drug conjugates (ADCs) continue to expand in breast cancer, understanding the potential cardiovascular risks is increasingly important, particularly in curative settings. 1789572000000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/25/13/59/FINE-HEART-Post-Hoc-Analysis In patients with cardio-kidney-metabolic (CKM) syndrome, comorbid cancer was frequent and independently associated with worse outcomes but did not affect the treatment benefit of finerenone, according to a post-hoc analysis of the FINE-HEART pooled analysis published Aug. 18 in EHJ. 1787759040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/24/16/23/accel-lite-24aug2026 In this interview, Dipti Itchhaporia MD, MACC and Ana Barac, MD, PhD, FACC discuss Umbrella: Cardioprotection During Treatment. 1787674980000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/03/15/28/Cardiotoxicity-Risk Immune checkpoint inhibitors (ICIs) are revolutionary oncologic therapies used frontline in several malignant neoplasms, including non–small cell lung cancer, melanoma, renal cell carcinoma, bladder cancer, and colorectal cancer. 1785780720000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/26/13/15/Ten-Points-to-Remember Pediatric cardio-oncology has expanded in scope over the past several decades to address the ever-increasing issues related to cardiovascular disease (CVD) in patients with and survivors of cancer, related both to treatment modalities and the disease itself. 1779816420000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/12/10/54/Management-of-Checkpoint-Inhibitor-Myocarditis-in-the-CCU A 75-year-old man with a history of remote anterior ST-segment elevation myocardial infarction and stage IV malignant melanoma treated with combination immunotherapy (ipilimumab/nivolumab) presented to the oncology clinic with 3 days of exertional dyspnea and 24 hours of diplopia and neck weakness. 1773320700000 Articles and Stories